Chemoinformaics analysis of trans-Zeatin glucoside
| Molecular Weight | 381.389 | nRot | 6 |
| Heavy Atom Molecular Weight | 358.205 | nRig | 18 |
| Exact Molecular Weight | 381.165 | nRing | 3 |
| Solubility: LogS | -1.593 | nHRing | 3 |
| Solubility: LogP | -1.128 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 10 |
| nHA | 11 | APOL | 52.3682 |
| nHD | 6 | BPOL | 30.5098 |
| QED | 0.311 |
| Synth | 4.663 |
| Natural Product Likeliness | 1.563 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.99 |
| HIA | 0.981 |
| CACO-2 | -5.719 |
| MDCK | 0.00000765 |
| BBB | 0.456 |
| PPB | 0.35928 |
| VDSS | 0.645 |
| FU | 0.695962 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.175 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.037 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.061 |
| CL | 4.51 |
| T12 | 0.928 |
| hERG | 0.024 |
| Ames | 0.075 |
| ROA | 0.336 |
| SkinSen | 0.125 |
| Carcinogencity | 0.045 |
| EI | 0.019 |
| Respiratory | 0.387 |
| NR-Aromatase | 0.904 |
| Antiviral | No |
| Prediction | 0.538199 |